Sanofi Anti-CD38 antibody Sarclisa investment Transaction

Fixed Income Investment Deal in France, Europe

Transaction Details

Name:Sanofi Anti-CD38 antibody Sarclisa investment
Amount:Available on swfi.com
Announced At:03/15/2022
Closed At:03/15/2022
RegionEurope
Country:France
Type:Deal
Security Type:Royalty
Investment Type:Fixed Income
SectorHealthcare
Industry:Pharmaceuticals
Summary:Available

Buyers

Entity 1
Asset Manager in United States		Stake
Available on swfi.com